LaboratoryCorporation

News

Reuters - 5 days ago

Labcorp Acquires Select Assets Of Lab Works

BRIEF-Labcorp Acquires Select Assets Of Lab Works Nov 20 (Reuters) - Labcorp Holdings Inc LH.N : LABCORP ACQUIRES SELECT ASSETS OF LAB WORKS Source text: [ID:] Further company coverage: LH.N

Reuters - 5 days ago

Cinven secures Italian nod to sell minority stake in Synlab to Labcorp

Cinven secures Italian nod to sell minority stake in Synlab to Labcorp ROME, Nov 20 (Reuters) - Private equity firm Cinven secured a conditional approval from Italian authorities over its plan to sell a 15% stake in diagnostic service provider Synlab to laboratory operator Labcorp LH.N , a government document sent to parliament showed. Golden powers legislation requires Italian government approval for any decision which results in changes in the ownership, control or availability of strategic as

Reuters - 5 days ago

U.S. Apellis Pharmaceuticals, Energizer Holdings, Walmart

U.S. RESEARCH ROUNDUP- Apellis Pharmaceuticals, Energizer Holdings, Walmart Nov 20 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Apellis Pharmaceuticals, Energizer Holdings and Walmart, on Wednesday. HIGHLIGHTS * Apellis Pharmaceuticals Inc APLS.O : JP Morgan cuts target price to $50 from $57 * Chord Energy Corp CHRD.O : RBC cuts target price to $180 from $185 * Energizer Holdings Inc ENR.N : JP Morgan raises to ne

Reuters - 5 days ago

U.S. STOCKS Merck, Microstrategy, Illumina

U.S. STOCKS ON THE MOVE-Merck, Microstrategy, Illumina Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 and the tech-heavy Nasdaq edged higher on Tuesday, paring earlier losses as investors assessed Russia's warning to the United States with a new nuclear doctrine, and awaited quarterly results from AI-heavyweight Nvidia.

Reuters - 5 days ago

U.S. STOCKS Merck, Microstrategy Inc, Zepp Health Corp

BUZZ-U.S. STOCKS ON THE MOVE-Merck, Microstrategy Inc, Zepp Health Corp Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes fell on Tuesday, as escalating tensions between Russia and Ukraine dented risk appetite globally and sent investors rushing for safe-haven assets.

Reuters - 5 days ago

U.S. STOCKS Piedmont Lithium, Berry, silver miners

BUZZ-U.S. STOCKS ON THE MOVE-Piedmont Lithium, Berry, silver miners Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures fell as concerns over escalating tensions between Russia and Ukraine affected risk appetite globally, with investors rushing to safe-haven assets.

Reuters - 6 days ago

Labcorp falls; decade-long CFO to retire

BUZZ-Labcorp falls; decade-long CFO to retire ** Shares of laboratory services provider Labcorp Holdings LH.N fall 1.7% to $234.49 premarket ** Co says Julia Wang to succeed Glenn Eisenberg as chief financial officer, effective Dec. 2, as incumbent retires after more than a decade in the position ** Wang most recently served as CFO at biotech firm

Reuters - 6 days ago

Labcorp CFO Glenn Eisenberg Announces Plans To Retire

BRIEF-Labcorp CFO Glenn Eisenberg Announces Plans To Retire Nov 19 (Reuters) - Labcorp Holdings Inc LH.N : LABCORP CFO GLENN EISENBERG ANNOUNCES PLANS TO RETIRE LABCORP: LABCORP CFO GLENN EISENBERG ANNOUNCES PLANS TO RETIRE LABCORP: JULIA WANG WILL JOIN ON DECEMBER 2, 2024, AS EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER LABCORP: EISENBERG

Reuters - 3 weeks ago

Praia Health Secures Strategic Investment From Labcorp Venture Fund, Announces New Collaboration To Streamline Patient Lab Ordering Experience

BRIEF-Praia Health Secures Strategic Investment From Labcorp Venture Fund, Announces New Collaboration To Streamline Patient Lab Ordering Experience Nov 4 (Reuters) - Labcorp Holdings Inc LH.N : PRAIA HEALTH SECURES STRATEGIC INVESTMENT FROM LABCORP VENTURE FUND, ANNOUNCES NEW COLLABORATION TO STREAMLINE PATIENT LAB ORDERING EXPERIENCE Source text:

Reuters - 4 weeks ago

U.S. STOCKS Newmont, Monopar Therapeutics, TKO Group

BUZZ-U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The Nasdaq jumped on Thursday, driven by Tesla's positive earnings forecast, which buoyed market sentiment despite declines from other corporate results and pressure from rising Treasury yields.

Reuters - 4 weeks ago

Labcorp Holdings Inc reports results for the quarter ended in September 30 - Earnings Summary

Labcorp Holdings Inc reports results for the quarter ended in September 30 - Earnings Summary Labcorp Holdings Inc LH.N reported quarterly adjusted earnings of $3.50 per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $3.38. The mean expectation of seventeen analysts for the quarter was for earnings of $3.48 per share.

Reuters - 4 weeks ago

U.S. STOCKS Teck Resources, Nasdaq, T-Mobile

BUZZ-U.S. STOCKS ON THE MOVE-Teck Resources, Nasdaq, T-Mobile Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 and the Nasdaq rebounded on Thursday, after Tesla's upbeat earnings forecast lifted market sentiment following a selloff in the previous session, kicking off megacap results on a promising note.

Reuters - 1 month ago

Labcorp's quarterly results beat on diagnostic tests demand

UPDATE 1-Labcorp's quarterly results beat on diagnostic tests demand Adds analyst comment in paragraphs 5-6, changes story keyword used by media customers to LABCORP HLDG-RESULTS/ Oct 24 (Reuters) - Laboratory operator Labcorp LH.N beat Wall Street estimates for third-quarter profit and revenue on Thursday as strong demand for diagnostic tests offset a hit from hurricane-led disruptions.

Reuters - 1 month ago

Labcorp beats quarterly estimates on diagnostic test demand

Labcorp beats quarterly estimates on diagnostic test demand Oct 24 (Reuters) - Laboratory operator Labcorp LH.N on Thursday beat Wall Street estimates for third-quarter profit and revenue, helped by demand for diagnostic tests. Diagnostic checkups have risen in recent quarters as more people, especially older adults, caught up on surgeries deferred during the pandemic.

Reuters - 1 month ago

US lab operator Quest Diagnostics to launch bird flu test at end of October

US lab operator Quest Diagnostics to launch bird flu test at end of October Oct 23 - Lab operator Quest Diagnostics DGX.N said on Wednesday it will launch a test for H5N1 bird flu at the end of October after the U.S. Centers for Disease Control and Prevention (CDC) gave it contracts to support testing for two emerging infectious diseases, including the Oropouche virus.

Reuters - 1 month ago

Labcorp Holdings Inc <LH.N> expected to post earnings of $3.49 a share - Earnings Preview

Labcorp Holdings Inc expected to post earnings of $3.49 a share - Earnings Preview Labcorp Holdings Inc LH.N , LH is expected to show a rise in quarterly revenue when it reports results on October 24 for the period ending September 30 2024 The Burlington North Carolina-based company is expected to report a 6.6% increase in revenue to $3.26 billion from $3.06 billion a year ago, according to the mean estimate from 13 analysts, based on LSEG data.

Reuters - 1 month ago

NOWDiagnostics And Labcorp Collaborate To Expand Access To The Only Marketing Authorized Over-The-Counter Syphilis Test In The U.S.

BRIEF-NOWDiagnostics And Labcorp Collaborate To Expand Access To The Only FDA-Marketing Authorized Over-The-Counter Syphilis Test In The U.S. Oct 16 (Reuters) - Labcorp Holdings Inc LH.N : NOWDIAGNOSTICS AND LABCORP COLLABORATE TO EXPAND ACCESS TO THE ONLY FDA-MARKETING AUTHORIZED OVER-THE-COUNTER SYPHILIS TEST IN THE U.S. Source text for Eikon: ID

Reuters - 2 months ago

Labcorp Expands Sexually Transmitted Infection Test Offerings With Rapid Syphilis Test

BRIEF-Labcorp Expands Sexually Transmitted Infection Test Offerings With Rapid Syphilis Test Oct 10 (Reuters) - Labcorp Holdings Inc LH.N : LABCORP EXPANDS SEXUALLY TRANSMITTED INFECTION (STI) TEST OFFERINGS WITH RAPID SYPHILIS TEST LABCORP: PLANS TO MAKE TEST AVAILABLE TO PROVIDERS BY END OF 2024 AND DIRECTLY TO PATIENTS THROUGH LABCORP ONDEMAND I

Reuters - 2 months ago

WHO approves first mpox diagnostic test for emergency use

UPDATE 4-WHO approves first mpox diagnostic test for emergency use Updates Oct. 3 story to add company statement in paragraph 4 Oct 3 (Reuters) - The World Health Organization authorized Abbott Laboratories' ABT.N mpox diagnostic test for emergency use on Thursday, the first such approval in the agency's effort to bolster testing capabilities in countries facing outbreaks of the disease.

Reuters - 2 months ago

U.S. Amerant Bancorp, BlackRock, Equinix

U.S. RESEARCH ROUNDUP-Amerant Bancorp, BlackRock, Equinix Oct 1 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Amerant Bancorp, BlackRock and Equinix, on Tuesday. HIGHLIGHTS * Amerant Bancorp Inc AMTB.N : Stephens raises to overweight from equal-weight * BlackRock BLK.N : JP Morgan raises target price to $864 from $774 * Equinix Inc EQIX.O : JP Morgan raises target price to $975 from $950 * Interpublic Group of Comp

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

How can we help?

Live Chat Terms